Stock-Based Compensation (Details) (USD $) | 3 Months Ended | 9 Months Ended | 12 Months Ended |
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Stock-based compensation in the form of employee stock options and restricted stock [Abstract] | ' | ' | ' | ' | ' |
Total stock-based compensation | $272,000 | $334,000 | $861,000 | $1,004,000 | ' |
Tax effect on stock-based compensation | 0 | 0 | 0 | 0 | ' |
Net effect on net income (loss) | 272,000 | 334,000 | 861,000 | 1,004,000 | ' |
Weighted average assumptions [Abstract] | ' | ' | ' | ' | ' |
Expected term | '4 years 4 months 24 days | ' | '4 years 3 months 18 days | ' | ' |
Volatility (in hundredths) | 62.26% | ' | 63.10% | ' | ' |
Expected dividend (in hundredths) | 0.00% | ' | 0.00% | ' | ' |
Risk-free interest rate (in hundredths) | 1.86% | ' | 1.88% | ' | ' |
Stock Options [Member] | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' |
Compensation costs related to unvested stock options not yet recognized | 1,300,000 | ' | 1,300,000 | ' | ' |
Value of estimated forfeitures | ' | ' | 46,000 | ' | ' |
Weighted-average period of amortization | ' | ' | '2 years 7 months 6 days | ' | ' |
Number of options outstanding [Roll Forward] | ' | ' | ' | ' | ' |
Options outstanding, beginning of period (in shares) | ' | ' | 2,671,000 | ' | ' |
Granted (in shares) | 200,000,000 | 60,000,000 | 252,000 | 60,000 | ' |
Exercised (in shares) | ' | ' | -112,000 | ' | ' |
Canceled and expired (in shares) | ' | ' | -73,000 | ' | ' |
Options outstanding, end of period (in shares) | 2,738,000 | ' | 2,738,000 | ' | 2,671,000 |
Options vested and expected to vest as of September 30, 2014 | 2,738,000 | ' | 2,738,000 | ' | ' |
Options exercisable as of September 30, 2014 | 1,688,000 | ' | 1,688,000 | ' | ' |
Weighted average exercise price [Roll Forward] | ' | ' | ' | ' | ' |
Options outstanding, beginning of period (in dollars per share) | ' | ' | $3.29 | ' | ' |
Granted (in dollars per share) | ' | ' | $2.26 | ' | ' |
Exercised (in dollars per share) | ' | ' | $1.21 | ' | ' |
Canceled and expired (in dollars per share) | ' | ' | $5.18 | ' | ' |
Options outstanding, end of period (in dollars per share) | $3.23 | ' | $3.23 | ' | $3.29 |
Options vested and expected to vest as of September 30, 2014 | $3.23 | ' | $3.23 | ' | ' |
Options exercisable as of September 30, 2014 | $3.52 | ' | $3.52 | ' | ' |
Weighted average Remaining Contractual Life [Abstract] | ' | ' | ' | ' | ' |
Options outstanding, beginning of period | ' | ' | '6 years 8 months 19 days | ' | '6 years 8 months 16 days |
Options outstanding, end of period | ' | ' | '6 years 8 months 19 days | ' | '6 years 8 months 16 days |
Options vested and expected to vest, end of period | ' | ' | '6 years 8 months 19 days | ' | ' |
Option exercisable, end of period | ' | ' | '5 years 5 months 8 days | ' | ' |
Aggregate Intrinsic Value [Abstract] | ' | ' | ' | ' | ' |
Options outstanding, beginning of period | ' | ' | 893,000 | ' | ' |
Options outstanding, end of period | 585,000 | ' | 585,000 | ' | 893,000 |
Options vested and expected to vest, end of period | 585,000 | ' | 585,000 | ' | ' |
Options exercisable, end of period | 505,000 | ' | 505,000 | ' | ' |
Closing price (in dollars per share) | $2.44 | ' | $2.44 | ' | ' |
Weighted Average Grant Date Fair Value [Roll Forward] | ' | ' | ' | ' | ' |
Weighted-average grant date fair value of stock options granted (in dollars per share) | $1.08 | $1.21 | $1.09 | $1.21 | ' |
Restricted Stock [Member] | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' |
Weighted-average period of amortization | ' | ' | '1 year 2 months 12 days | ' | ' |
Shares [Roll Forward] | ' | ' | ' | ' | ' |
Non-vested, beginning of period (in shares) | ' | ' | 241,232 | ' | ' |
Granted (in shares) | ' | ' | 55,044 | ' | ' |
Vested (in shares) | ' | ' | -48,420 | ' | ' |
Non-vested, end of period (in shares) | 247,856 | ' | 247,856 | ' | ' |
Weighted Average Grant Date Fair Value [Roll Forward] | ' | ' | ' | ' | ' |
Non-vested, beginning of period (in dollars per share) | ' | ' | $3.44 | ' | ' |
Granted (in dollars per share) | ' | ' | $2.18 | ' | ' |
Vested (in dollars per share) | ' | ' | $4.66 | ' | ' |
Non-vested, end of period (in dollars per share) | $2.92 | ' | $2.92 | ' | ' |
Unrecognized compensation expense related to restricted stock awards | 514,000 | ' | 514,000 | ' | ' |
Cost of Revenue [Member] | ' | ' | ' | ' | ' |
Stock-based compensation in the form of employee stock options and restricted stock [Abstract] | ' | ' | ' | ' | ' |
Total stock-based compensation | 4,000 | 6,000 | 14,000 | 17,000 | ' |
Selling, General and Administrative [Member] | ' | ' | ' | ' | ' |
Stock-based compensation in the form of employee stock options and restricted stock [Abstract] | ' | ' | ' | ' | ' |
Total stock-based compensation | 227,000 | 285,000 | 716,000 | 860,000 | ' |
Research and Development [Member] | ' | ' | ' | ' | ' |
Stock-based compensation in the form of employee stock options and restricted stock [Abstract] | ' | ' | ' | ' | ' |
Total stock-based compensation | $41,000 | $43,000 | $131,000 | $127,000 | ' |